Business Description
Zivo Bioscience Inc
NAICS : 325412
SIC : 2834
ISIN : US98978N3098
Total Employee Number:
7Description
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | -5.88 | |||||
Debt-to-Equity | -0.25 | |||||
Debt-to-EBITDA | -0.1 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -413.74 | |||||
Beneish M-Score | -47.47 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.3 | |||||
3-Year EPS without NRI Growth Rate | 15.4 | |||||
3-Year FCF Growth Rate | 36.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 41.18 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 168.12 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 33.1 | |||||
9-Day RSI | 40.8 | |||||
14-Day RSI | 44.92 | |||||
3-1 Month Momentum % | 14.16 | |||||
6-1 Month Momentum % | -61.62 | |||||
12-1 Month Momentum % | -62.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.08 | |||||
Quick Ratio | 0.08 | |||||
Cash Ratio | 0.02 | |||||
Days Sales Outstanding | 37.26 | |||||
Days Payable | 1962.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.1 | |||||
Shareholder Yield % | -14.48 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.58 | |||||
Operating Margin % | -4045.93 | |||||
Net Margin % | -4059.81 | |||||
EBITDA Margin % | -4046.89 | |||||
FCF Margin % | -1473.21 | |||||
OCF Margin % | -1473.21 | |||||
ROA % | -896.56 | |||||
ROIC % | -431.16 | |||||
3-Year ROIIC % | 478.88 | |||||
ROC (Joel Greenblatt) % | -3848.92 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 71.43 | |||||
EV-to-EBIT | -2.05 | |||||
EV-to-EBITDA | -2.05 | |||||
EV-to-Revenue | 83.11 | |||||
EV-to-FCF | -5.64 | |||||
Earnings Yield (Greenblatt) % | -48.78 | |||||
FCF Yield % | -18.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZIVO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zivo Bioscience Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.209 | ||
| EPS (TTM) ($) | -2.18 | ||
| Beta | 0.1322 | ||
| 3-Year Sharpe Ratio | 0.42 | ||
| 3-Year Sortino Ratio | 1.98 | ||
| Volatility % | 97.06 | ||
| 14-Day RSI | 44.92 | ||
| 14-Day ATR ($) | 0.382638 | ||
| 20-Day SMA ($) | 4.567365 | ||
| 12-1 Month Momentum % | -62.34 | ||
| 52-Week Range ($) | 1.105 - 19.65 | ||
| Shares Outstanding (Mil) | 4.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zivo Bioscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zivo Bioscience Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 101 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 10 days | ||
| General meeting for 2026 | 2026-08-05 | In 1 day | ||
| Life Sciences Virtual Investor Forum | 2026-06-24 14:00 | 4.30 (+38.76%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 3.69 (+36.67%) | ||
| Annual report for 2025 | 2026-05-07 | 4.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 12.25 (-2.33%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 18.22 (+1.28%) | ||
| General meeting for 2025 | 2025-06-09 10:00 | 17.21 (-0.23%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 18.00 (+0.00%) |
Show
Entries
Zivo Bioscience Inc Frequently Asked Questions
What is Zivo Bioscience Inc(ZIVO)'s stock price today?
The current price of ZIVO is $4.00. The 52 week high of ZIVO is $19.65 and 52 week low is $1.11.
When is next earnings date of Zivo Bioscience Inc(ZIVO)?
The next earnings date of Zivo Bioscience Inc(ZIVO) is 2026-08-14 Est..
Does Zivo Bioscience Inc(ZIVO) pay dividends? If so, how much?
Zivo Bioscience Inc(ZIVO) does not pay dividend.
Guru Commentaries on OTCPK:ZIVO
No articles.
Press Release
Articles on Zivo Bioscience Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers